Follow the Pundits
Tag: John Paulson
🏔️ John Paulson 2025: From "Short of the Century" to the "Long of the Decade"
John Paulson is back. After years under the radar, the legendary investor posted a 58% return in 2025—driven by high-conviction bets in biotech, gold, and strategic minerals. This is not diversification. This is precision investing.
John Paulson’s $5,000 Gold Bet: Genius or Gamble? 🚀
A hyper-concentrated portfolio, a $5,000 gold target, and massive biotech bets—John Paulson is back with one of the boldest strategies in markets today.
Paulson & Co Keeps Adding to His Bausch Health Stake: Should Investors See Eye to Eye With Him?
Billionaire John Paulson now owns nearly 19% of Bausch Health — and he keeps buying. With improving earnings, low valuation, and high risk, BHC may be a speculative value play worth watching.
John Paulson Is Loading Up on Perpetua Resources. Should You?
John Paulson knows a good discount when he sees one—and he just grabbed another $100M worth of Perpetua Resources (PPTA). But what is this gold-and-antimony play really about? From Idaho mines to strategic minerals and a wink at squirrel invasions, we break it all down.
Bausch Health: Paulson Doubles Down, Stock Breaks Out, Recovery Accelerates
Bausch Health ($BHC) is back in the spotlight as legendary investor John Paulson adds millions more in shares, fueling a breakout rally. With Q2 earnings showing revenue growth, profit rebound, and debt repayment plans, could BHC be staging its long-awaited comeback?